ClinicalTrials.Veeva

Menu

The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study

J

Ju Seok Ryu

Status

Completed

Conditions

Cerebral Palsy

Treatments

Drug: medication Botulinum A injection.

Study type

Interventional

Funder types

Other

Identifiers

NCT03680196
B-1807-478-001

Details and patient eligibility

About

In children with cerebral palsy, secondary problems lead to hip dislocation. the purpose of this study is to find out the effects of botulinum toxin A on hip joint dislocation in cerebral palsy patients.

Full description

  • Design: Prospective study
  • Inclusion criteria of patient group: who has a cerebral palsy and GMFCS level 3,4,5
  • Intervention: applied medication Botulinum A injection (meditox 200unit)
  • Main outcome measures: The investigators will measure for finding evidence by checking the x-ray photograph, hip adductor and muscles pressure test and electromyography(EMG test) test of hip adductor, abductor and spine muscles.

Enrollment

20 patients

Sex

All

Ages

2 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Severe cerebral palsy patients(GMFCS level 3,4,5)
  • 2 to 10 years old

Exclusion criteria

  • Those who disagree with the study.
  • other than cerebral palsy.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

cerebral palsy patients
Experimental group
Description:
cerebral palsy patients who have GMFCS level3,4,5 and 2 years old and under 10 years old apply an A injection of medication Botulinum A injection
Treatment:
Drug: medication Botulinum A injection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems